Acutus Medical, Inc. AFIB
0.00 USD 0.00 (+0.00%)
At closeNov 5, 2026, 4:00 PM EST
0.0005 Day range 0.0005
0.0001 52-week range 0.0039
- YTD
- -50.00%
- 1 year
- -66.67%
- Market cap
- 2.99K
- Revenue (ttm)
- 9.55M
- EPS (ttm)
- -0.15
- Shares out
- 29.72M
- Forward P/E
- -0.02
- YTD return
- -50.00%
- 1-year return
- -66.67%
- Volume
- 10.00K
- Avg volume
- 3.33K
- Open
- 0.0005
- Previous close
- 0.0001
- Day's range
- 0.0005 – 0.0005
- 52-week range
- 0.0001 – 0.0039
- Beta
- 0.04
- Analysts
- Hold
ALL -26.7899 (-100.00%)
Key statistics
- Enterprise value
- 19.91M
- PEG ratio
- 0.00
- Price / sales
- 0.14
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 191.90%
- Free cash flow
- -2.76M
- Total cash
- 19.95M
- Total debt
- 38.47M
- Return on equity
- -34.36%
- Short % of float
- 1.91%
- 50-day average
- 0.11682
- 200-day average
- 0.289225
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
AFIB Revenue — quarterly 3.63M
AFIB Net income — quarterly -1.62M
AFIB EPS — quarterly -0.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.03 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.07 | — | — |
| Nov 8, 2023 | Sep 1, 2023 | -0.57 | -0.45 | +0.12 | +21.05% |
| Aug 7, 2023 | Jun 1, 2023 | -0.61 | -0.63 | -0.02 | -3.28% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2022 | Goldman Sachs | main | — | Neutral |
| Jun 23, 2022 | BTIG | main | — | Buy |
| Apr 26, 2022 | BTIG | up | Neutral | Buy |
| Apr 13, 2022 | Goldman Sachs | main | — | Neutral |
| Jan 19, 2022 | BTIG | down | Buy | Neutral |
| Jan 13, 2022 | Canaccord Genuity | down | Buy | Hold |
About Acutus Medical, Inc.
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- acutusmedical.com
News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Monday
Earnings Scheduled For August 7, 2023
Earnings Scheduled For May 11, 2023
Your note
Sign in to keep a note on AFIB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BONITA DAVID P | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
| ELBARDISSI ANDREW | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
| FLYNN JAMES E | Director | Stock Award(Grant) | Jun 14, 2023 | 0 |
| GARLAND JASON K. | Director | Stock Award(Grant) | Jun 14, 2023 | 22,400 |
| HUENNEKENS R SCOTT | Director | Stock Award(Grant) | Jun 14, 2023 | 529,349 |
| MARZOUK SHADEN | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 9.09% | 2,660,808 | 2.36M | Jun 29, 2023 |
| Orbimed Advisors LLC. | 9.05% | 2,648,386 | 2.35M | Jun 29, 2023 |
| Vanguard Group Inc | 3.90% | 1,140,706 | 1.01M | Jun 29, 2023 |
| Parkman Healthcare Partners LLC | 2.60% | 762,025 | 676.68K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 1.26% | 369,900 | 328.47K | Jun 29, 2023 |
| American Financial Group Inc. | 1.03% | 299,995 | 266.39K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.85% | 835,044 | 741.52K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.95% | 278,220 | 247.06K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.35% | 103,149 | 87.68K | May 30, 2023 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.27% | 79,500 | 70.60K | Jun 29, 2023 |
| Fidelity Series Total Market Index Fund | 0.09% | 25,878 | 22.00K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.08% | 22,522 | 19.14K | May 30, 2023 |
